ACNE-STATIN ADVERTISING WILL BE MODIFIED IN PART
This article was originally published in The Tan Sheet
Executive Summary
ACNE-STATIN ADVERTISING WILL BE MODIFIED IN PART following an inquiry by the National Advertising Division of the Council of Better Business Bureaus into print advertising and a 30-minute televised infomercial for the acne treatment kit, NAD announced Jan. 11. In response to recommendations from NAD, Eton-Derma Labs said it will modify its use of a photographic testimonial representing a severe acne condition. The advertiser also said it will clarify its product-attribute claims to specify which of the kit's products is being discussed and will clarify a sensitive skin claim, a claim for no side-effects and a claim for uniqueness.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning